WAVLD Symposium Handbook_V4.indd - csiro
WAVLD Symposium Handbook_V4.indd - csiro
WAVLD Symposium Handbook_V4.indd - csiro
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
World Association of Veterinary Laboratory Diagnosticians – 13 th International <strong>Symposium</strong>, Melbourne, Australia, 11-14 November 2007<br />
1100 - 1230 Concurrent Session 1.1 - New & Emerging Diseases/Wildlife Mon<br />
EXPERIMENTAL MODELS FOR HENIPAVIRUS INFECTION: BATS, CATS AND PSEUDO-RATS.<br />
12<br />
Bruce A. Mungall, Deborah J. Middleton, Kim Halpin, Peter Daniels, and John Bingham.<br />
Australian Animal Health Laboratory, CSIRO Livestock Industries, 5 Portarlington Rd, Geelong, Australia<br />
Introduction:<br />
November<br />
Hendra virus (HeV) and Nipah virus (NiV), comprising the genus Henipavirus, family Paramyxoviridae, have<br />
been responsible for numerous outbreaks of zoonotic disease in livestock and humans. Bats of the genus<br />
Pteropus have been identified as the reservoir hosts for these viruses. However, how virus spills over from<br />
the reservoir host has remained a mystery. Nipah virus has continued to re-emerge in Asia, specifically<br />
Bangladesh, since 2001, with case fatality rates as high as 92%. As there are no currently available vaccines<br />
or antivirals indicated for Henipavirus infection, possible therapeutic and prophylactic options in the treatment<br />
and prevention of Nipah virus disease has been seen as a priority in this field of research. In addition to<br />
novel emerging pathogens, Henipaviruses are also BSL4 agents that possess several biological features<br />
that make them highly adaptable for use as bioterror agents. Clearly, there is a high level of public health<br />
importance attributed to Henipaviruses, and by inference, a considerable risk associated with new<br />
emergence events by other unknown or as yet, uncharacterised paramyxoviruses.<br />
Material & methods:<br />
Understanding the amplifying host, the routes of transmission, the type of susceptible human hosts, and the<br />
epicentres for zoonotic and human transmissions is crucial in the control of zoonotic infections. There have<br />
been multiple recent paramyxovirus emergence events, many of these involving bats. Some of these newly<br />
emerged viruses are highly pathogenic (henipaviruses), some are moderately pathogenic (Menangle, PoRV,<br />
PPMV) while many are of unknown pathogenicity (Tioman, Mapuera, SalV, TPMV). The development or<br />
characterization of animal models to study these newly identified viral zoonoses is important for<br />
understanding their pathogenic features and in the development of therapeutics or vaccines. In order to<br />
address the different angles of Henipavirus research, we have developed a range of experimental animal<br />
models including bats, pigs, cats, guinea pigs and ferrets, all amenable to BSL4 conditions. This<br />
presentation describes these models.<br />
Results:<br />
While the human symptoms of NiV infection range from fever and headache to severe acute febrile<br />
encephalitis [1], the porcine disease is primarily a febrile respiratory illness with or without neurological signs<br />
[3]. In both humans and pigs, NIV pathogenesis appears to be related to a systemic vasculitis [3, 5] and<br />
experimental infection of cats, hamsters and ferrets has revealed a similar underlying pathology [3, 4, 6]<br />
(Middleton, unpublished data). While guinea pigs have also been experimentally infected with HeV [2]<br />
(Halpin et al., Manuscript in preparation) and NiV (Halpin et al., Manuscript in preparation), the pathology<br />
differed significantly in several respects from the human cases and from naturally and experimentally<br />
infected horses. NiV and HeV do not cause disease in mice even after subcutaneous administration, and<br />
there is no serological evidence for NiV in rodents in Malaysia. However, and not surprisingly, HeV and NiV<br />
will kill mice if administered intracranially but the lack of natural infection precludes the establishment of<br />
useful rodent models.<br />
Discussions & conclusions:<br />
While the cat represents the animal model in which the pathology most closely resembles the lethal disease<br />
course in humans, and will provide an excellent model for some studies, the ferret provides an excellent<br />
more economical model for preliminary therapeutic testing. The high level of similarity between the two<br />
viruses enables therapeutic studies to be carried out for both pathogens in parallel in ferrets followed by cats.<br />
References:<br />
1. Goh et al., Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J<br />
Med, 2000. 342(17): p. 1229-35.<br />
2. Hooper et al., Lesions of experimental equine morbillivirus pneumonia in horses. Veterinary<br />
Pathology, 1997. 34: p. p312-322.<br />
3. Middleton etal., Experimental Nipah virus infection in pigs and cats. J Comp Pathol, 2002. 126(2-3):<br />
p. 124-36.<br />
4. Mungall et al., Feline model of acute nipah virus infection and protection with a soluble glycoproteinbased<br />
subunit vaccine. J Virol, 2006. 80(24): p. 12293-302.<br />
5. Wong et al., Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral<br />
zoonosis. Am J Pathol, 2002. 161(6): p. 2153-67.<br />
6. Wong et al., A golden hamster model for human acute Nipah virus infection. Am J Pathol, 2003.<br />
163(5): p. 2127-37.<br />
Mon 12 November<br />
World Association of Veterinary Laboratory Diagnosticians – 13 th International <strong>Symposium</strong>, Melbourne, Australia, 11-14 November 2007<br />
THE EMERGENCE OF CANINE INFLUENZA IN THE USA: THE RELATIONSHIP TO<br />
EQUINE INFLUENZA AND DEVELOPMENTS SINCE DISCOVERY IN 2004.<br />
P.C. Crawford 1 , T.L. Anderson 1 , W.L. Castleman 1 , M.T. Long 1 , R.O. Donis 2 , T.E. Chambers 3 ,<br />
E.P.J. Gibbs 1* .<br />
1 College of Veterinary Medicine, University of Florida, Gainesville, FL, USA.<br />
2 Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.<br />
3 OIE International Reference Laboratory for Equine Influenza, Gluck Equine Research Center, University of Kentucky, Lexington, KY,<br />
USA.<br />
In 2004, an influenza virus was isolated from an outbreak of severe respiratory diseases in racing<br />
greyhounds at a track in Florida. Several dogs died of pulmonary haemorrhage. An influenza virus was<br />
isolated and the entire genome was sequenced. It was concluded that all eight genes had originated from<br />
equine influenza virus (H3N8), consistent with cross-species transfer from horse to dog. The details of the<br />
discovery of canine influenza and the characterization of the virus have been published (Crawford et al.<br />
2005, Science 310, 482-485). This paper reviews the features of subsequent outbreaks of canine influenza<br />
in Florida and other states within the USA, and reports on the susceptibility of horses to the canine isolate.<br />
Since 2004, canine influenza has been confirmed in multiple outbreaks of respiratory disease at greyhound<br />
tracks throughout the USA and the virus has spread into the pet dog population, particularly those dogs<br />
housed in shelters. The disease has been confirmed by serology and virus isolation in pet dogs in 25 states<br />
in the contiguous USA. Molecular characterizations of recent isolates indicate that the virus is continuing to<br />
evolve. Horses experimentally inoculated with the canine virus were infected as evidenced by<br />
seroconversion and virus replication in pulmonary tissues, but clinical disease was mild.<br />
The paper will discuss the relevance of this discovery to the recent epidemic of equine influenza in Australia.